Content by The Scientist Creative Services Team

Researchers seek genomic clues to understand differences in the immune response to infection.

An expert panel will describe their efforts to chart billions of neuronal connections and discuss how this data provides unparalleled insight into neuronal cell biology, signal processing, and behavior.

A cost-effective 3-D organoid biobank provides a versatile translational research tool.

Silica-gold nanoshells highlight how good probe design can boost assay performance.

Discover how to best map a cell’s epigenetic landscape

Andrea Kasinski and Masako Harada will discuss the role of microRNAs in cancer, as well as the potential and challenges of using microRNAs for cancer therapeutics.

Sebastian Lewandowski and Philip Hasel will discuss using single-cell techniques to understand the role of rare cell subtypes in neuroinflammation and neurodegeneration.

Embark on the journey of cell and gene therapy—from its conception and development, to its present state, and into its future.

Learn how to balance sample limitations and experimental methods for optimal single-cell sequencing results.

In this workshop, learn how to make precision medicine a reality by modeling human cancers in 3-D organoid cultures for drug screening.

Dario Vignali and Peter Westcott will explore the importance of understanding immune-cancer mechanistic interactions for developing therapeutic approaches.

An automated, microfluidic immunoassay system enables researchers to quickly and reliably measure cytokines in patient blood samples.

An animal component-free culture medium provides a safe and robust alternative for maintaining induced pluripotent stem cells.

An expert panel will discuss how single cell sequencing enhances throughput in CRISPR gene editing applications.

An expert panel will discuss how a functional cell library confirms critical insights from previous omics studies. Additionally, they will introduce an innovative platform that connects single cell transcriptomics with functional proteomics for the first time.